FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]
Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2616698017 | Oral capsule | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3635963017 | Conventional release oral capsule | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3635964011 | Conventional release oral capsule (dose form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Oral capsule | Is a | Capsule | false | Inferred relationship | Some | ||
| Oral capsule | Is a | Oral dose form | true | Inferred relationship | Some | ||
| Oral capsule | Has dose form intended site (attribute) | Oral | true | Inferred relationship | Some | ||
| Oral capsule | Has dose form administration method (attribute) | Swallow (administration method) | true | Inferred relationship | Some | ||
| Oral capsule | Has dose form transformation (attribute) | No transformation | true | Inferred relationship | Some | ||
| Oral capsule | Has dose form release characteristic (attribute) | Conventional release (release characteristic) | true | Inferred relationship | Some | ||
| Oral capsule | Has basic dose form (attribute) | Capsule | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Nilotinib (as nilotinib hydrochloride) 50 mg oral capsule | Has manufactured dose form | True | Oral capsule | Inferred relationship | Some | |
| Product containing precisely fingolimod (as fingolimod hydrochloride) 250 microgram/1 each conventional release oral capsule (clinical drug) | Has manufactured dose form | True | Oral capsule | Inferred relationship | Some | |
| Product containing precisely lenalidomide 7.5 milligram/1 each conventional release oral capsule (clinical drug) | Has manufactured dose form | True | Oral capsule | Inferred relationship | Some |
This concept is not in any reference sets